Arcadia Biosciences (RKDA)
Nasdaq Market Open
Arcadia Biosciences, Inc. is a consumer-focused food and agricultural products company with roots in crop science and trait development. The company has shifted from a primarily agricultural biotechnology profile toward branded consumer goods, while retaining selected intellectual property and product opportunities connected to agronomic traits. Its current reported revenue base is led by Zola coconut water, a packaged beverage brand sold into the US consumer market.
Arcadia’s portfolio spans food, beverage, body care and agricultural applications. Zola Coconut Water gives the company exposure to the better-for-you beverage category, where brands compete on taste, distribution, retail shelf space and consumer interest in hydration and natural ingredients. The company’s agricultural history includes work on wheat traits and other plant-science applications designed to improve crop performance or end-market value, although its commercial focus has narrowed compared with earlier stages of the business.
The company reports one operating segment and generates most of its revenue in the United States. It also has geographic links to markets including Argentina, India and Canada, reflecting the international nature of agricultural research, trait licensing and crop commercialization. Arcadia’s scale is small compared with major food, beverage and agricultural input companies, so its results can be sensitive to brand traction, distribution agreements, working capital needs and portfolio changes.
For investors, Arcadia Biosciences represents a niche small-cap company combining consumer packaged goods with a legacy in agricultural innovation. Its distinctive feature is the blend of branded products such as Zola and science-based assets tied to crop development, rather than a pure-play beverage, personal care or seed technology model.
Last updated
- Market Cap
- 2.06M
- P/E
- —
- P/FCF
- —
- P/S
- 0.43
- Enterprise Value
- 1.1M
- Sector
- Energy
- Industry
- Crude Petroleum and Natural Gas
- Address
- 5956 SHERRY LANE, DALLAS, TX
Arcadia acquires ENGIE Impact to create best-in-class energy management platform
Cority Continues to Be a Leader in the Sustainability Software Market, According to Prominent Industry Analyst Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CCRN, RKDA, ENLC on Behalf of Shareholders
Arcadia Biosciences Announces Executive Changes - Investing.com
Arcadia Biosciences (RKDA) Sells GoodWheat Brand to Above Food
Arcadia Biosciences (RKDA) Reports Q1 Loss, Tops Revenue Estimates
Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Arcadia Biosciences (RKDA) Q4 Earnings Beat Mark, Sales Up Y/Y
New Strong Buy Stocks for October 17th
Arcadia Biosciences (RKDA) Reports Q2 Loss, Misses Revenue Estimates
5 Stocks With Rising P/E to Bet on for Solid Gains
The Andersons (ANDE) Surpasses Q2 Earnings Estimates
Zacks Industry Outlook Highlights Bunge, CalMaine Foods and Arcadia Biosciences
3 Stocks to Watch in the Promising Agriculture - Products Industry
3 Stocks Worth a Look in the Thriving Agriculture - Products Industry
Hecla Mining (HL) Reports Q3 Loss, Misses Revenue Estimates
Bunge (BG) Q3 Earnings and Revenues Beat Estimates
3 Stocks to Watch in the Promising Agriculture - Products Industry
Best Penny Stocks To Buy? 4 Under $3 To Watch Now
3 Penny Stocks That Climbed Today, Here’s Why
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 2.06M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 1.1M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.71
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.43
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -0.29
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.23
- EPS
- -4.53
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- —
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -323.15%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -175.15%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 3.79
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 3.17
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.7
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 2.11M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 1
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 1.1M | 901K | 1.3M | 1.46M | 1.2M |
| Gross profit | 400K | 192K | 418K | 631K | 518K |
| Operating income | -779K | -1.38M | -1.15M | -501K | 530K |
| EBITDA | -771K | -1.37M | -1.15M | -486K | 543K |
| Net income | -4.39M | -1.34M | 856K | -4.46M | 2.6M |
| Basic EPS | -2.11 | -0.98 | 0.63 | -3.26 | 1.9 |
| Diluted EPS | -2.11 | -0.98 | 0.62 | -3.26 | 1.9 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 5.32M | 6.55M | 8.58M | 7.79M | 12.99M |
| Total liabilities | 2.44M | 2.41M | 3.14M | 3.26M | 4.09M |
| Total equity | 2.89M | 4.14M | 5.44M | 4.53M | 8.91M |
| Cash & equivalents | 954K | 259K | 1.12M | 1.38M | 3.16M |
| Current assets | 5.17M | 6.36M | 8.39M | 7.58M | 8.85M |
| Current liabilities | 1.37M | 2.06M | 2.29M | 1.84M | 2.22M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -1.1M | -861K | -257K | -2.03M | -1.59M |
| Investing cash flow | — | 0 | 0 | 250K | 500K |
| Financing cash flow | 1.79M | 0 | 1K | 0 | 5K |
| Change in cash | 695K | -861K | -256K | -1.78M | -1.08M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | SCHEDULE 13G — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 10-Q — Arcadia Biosciences, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 10-K — Arcadia Biosciences, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 424B3 — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | EFFECT — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | UPLOAD — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | CORRESP — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | S-3 — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | CORRESP — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | D — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | RW — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 425 — Arcadia Biosciences, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | ARS — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 10-Q — Arcadia Biosciences, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 425 — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 10-Q — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | S-4/A — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 4 — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 4 — Arcadia Biosciences, Inc. | View Filing | |
| form 4 | Form 4 — Schaefer Thomas J. | View Filing | |
| form 4 | Form 4 — Kawakami Mark | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 425 — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 10-Q — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 425 — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 10-K/A — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 10-K — Arcadia Biosciences, Inc. | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | S-4 — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 4 — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 4 — Arcadia Biosciences, Inc. | View Filing | |
| form 4 | Form 4 — Schaefer Thomas J. | View Filing | |
| form 4 | Form 4 — Kawakami Mark | View Filing | |
| edgar index | SCHEDULE 13G/A — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 425 — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 425 — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | S-8 — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 8-K — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 10-Q — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 8-K/A — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 4 — Arcadia Biosciences, Inc. | View Filing | |
| edgar index | 4 — Arcadia Biosciences, Inc. | View Filing |